Alteration in human granulocyte function after in vitro incubation with L-ascorbic acid.
D001205:Ascorbic Acid / Q000494:pharmacology*; D002176:Candida albicans; D006098:Granulocytes / Q000187:drug effects* / Q000502:physiology; D006600:Hexosephosphates / Q000378:metabolism; D006801:Humans; D007962:Leukocytes / Q000187:drug effects*; D010101:Oxygen Consumption / Q000187:drug effects; D010587:Phagocytosis / Q000187:drug effects; D013211:Staphylococcus aureus; D015054:Zymosan / Q000378:metabolism
D006600:Hexosephosphates; D015054:Zymosan; D001205:Ascorbic Acid